[In-Person] How Founders Can De-risk Growth: Product Regulation and Strategic Contracts for AI, Digital Health, and Life Sciences Startup

​How Founders Can De-risk Growth: Product Regulation and Strategic Contracts for AI, Digital Health, and Life Sciences Startups

​As AI, digital health, diagnostics, and life sciences startups move from product development to commercialization, navigating regulatory requirements and strategic contracts can be critical to de-risking growth.

​Join StartX and Covington for a roundtable/workshop designed to help founders identify regulatory and contracting considerations early — before they become obstacles to fundraising, commercialization, partnerships, or customer growth.

​The session will cover:

• ​Navigating the regulatory landscape: Key FDA, EU/UK, and other regulatory requirements applicable to software, AI-enabled tools, diagnostics, medical devices, and digital health platforms.

• ​Determining whether your product is regulated: How to assess regulatory status and think strategically about structuring a commercialization pathway.

• ​Avoiding contractual pitfalls: Key traps for the unwary when entering into IP-driven contracts with healthcare systems, biopharma companies, vendors, and other customers and partners.

• ​De-risking growth: Practical considerations for aligning regulatory strategy, product development, commercialization, and contracting as your company scales.

​Speakers

​Sarah Cowlishaw
Partner — Life Sciences, Digital Health, Medical Devices

​Amy Leiser
Special Counsel — FDA, Medical Devices, Diagnostics, Digital Health

​Vinita Kailasanath
Partner — Technology & Life Sciences Transactions, AI, Digital Health

​Whether you're preparing to launch a regulated product, entering into your first major enterprise partnership, or scaling an existing commercial strategy, this workshop will provide founders with practical frameworks for identifying risks and making informed decisions as they grow.